Company Analysis

Coherus Oncology, Inc. (CHRS)

Nasdaq: CHRS · Biological Products, (No Diagnostic Substances) · Redwood City, CA · filing with the SEC since 2011
Grade4.8
◀ Past 3.5● Present 5.6▶ Future 5.0
1 est.

Who owns Coherus Oncology, Inc.

As filed with the SEC
Holders of 5% or more
3
Timothy G. Youngquist 2020 Irrevocable Trust holds 8.3% of Common Stock, $0.0001 par value per share, as its SCHEDULE 13G/A filed May 15, 2026 says.
Directors and officers
9
report now, of 28 people on the record since 2014. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Timothy G. Youngquist 2020 Irrevocable Trust
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, $0.0001 par value per share · n/a in May 11, 2026
8.3%
Evgeny Zaytsev ("Zaytsev")
SCHEDULE 13G · filed Nov 4, 2025 · Common Stock, $0.0001 par value per share
6.5%
Blackrock, Inc.
SCHEDULE 13G · filed Jul 27, 2026 · Common Stock · 4.9% in Apr 27, 2026
5.8%
Thomas A. Satterfield, Jr.
SCHEDULE 13G/A · filed Apr 29, 2026 · Common Stock, $0.0001 par value per share · reported falling below 5%, from 5.2% in Apr 16, 2025
under 5%
Rubric Capital Management LP
SCHEDULE 13G/A · filed Feb 13, 2025 · Common Stock, $0.0001 par value · reported falling below 5%
under 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%, from 8.29% in Jan 30, 2026
under 5%
What CHRS reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Surface
An entity · legal entity · owns, named in the 10-K filed Mar 9, 2026

1 subsidiary in 1 country, from the list filed with the 10-K filed Mar 9, 2026.

Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
151617181920212325
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.
SI Assistanton CHRS · research, not advice